Dwo Yuan Sia | Chief Technology Officer
BravoVax Co Ltd | China

Dwo Yuan Sia, Chief Technology Officer, BravoVax Co Ltd

Charles Dwo Yuan SIA is the Chief Technology Officer of BravoVax. He was an Investigator (Professor) of National Institute of Infectious Diseases and Vaccinology at National Health Research Institutes, Taiwan. Prior of joining NHRI, he was the Director of Immunology and Vaccinology in UBI (USA) and, subsidiaries in UBIAsia (Taiwan, ROC) and UBI (Shanghai), where he is instrumental in bringing FMDV vaccine to China market, and completed the Phase I clinical trial testing of Alzheimer’s Disease vaccine in 2008 in Taiwan.


Phar-East Day 1 @ 16:40

Beyond prevention: Latest cancer vaccine developments in Asia

last published: 19/Feb/19 03:35 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738